News
The pact was backed in Geneva by the WHO’s annual World Health Assembly of member states after winning support in a committee ...
The decision means many Americans without underlying conditions may not have access to updated shots. "The FDA will approve ...
The World Health Organization's member countries have approved an agreement to better prevent, prepare for and respond to ...
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will ...
FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other groups at high risk for severe illness.
WHO members on Tuesday adopted a treaty that outlines how to prepare for and respond to pandemics. One country missing: the U ...
The FDA announced it will limit full approval of future COVID-19 booster vaccines to individuals older than 65 and those at high risk for severe disease, marking a shift from the agency’s previous one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results